Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer
Go back to Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer| (NASDAQ: AKTX) | Delayed: 8.24 +0.24 (3.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.00 | 52 Week High | $19.75 | |||
| Open | $8.50 | 52 Week Low | $7.63 | |||
| Day High | $8.97 | P/E | N/A | |||
| Day Low | $8.07 | EPS | $0.00 | |||
| Volume | 45,801 | |||||
| (NASDAQ: AKTX) | Delayed: 8.24 +0.24 (3.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.00 | 52 Week High | $19.75 | |||
| Open | $8.50 | 52 Week Low | $7.63 | |||
| Day High | $8.97 | P/E | N/A | |||
| Day Low | $8.07 | EPS | $0.00 | |||
| Volume | 45,801 | |||||



